bucladesine has been researched along with Cardiomyopathies, Primary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, SY | 1 |
| De Mello, WC | 1 |
| Ebbesen, P | 1 |
3 other study(ies) available for bucladesine and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
Topics: Amrinone; Animals; Blood Pressure; Bucladesine; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Digoxin; Disease Models, Animal; Dobutamine; Energy Metabolism; Heart Failure; Isoproterenol; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardial Contraction; Oxygen Consumption; Phosphates; Phosphorylation | 1995 |
Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Atrial Natriuretic Factor; Bucladesine; Cardiomyopathies; Cell Communication; Cricetinae; Cyclic GMP; Electrophysiology; Gap Junctions; Heart Failure; Heart Ventricles; Male; Mesocricetus; Phosphodiesterase Inhibitors; Purinones; Receptors, Atrial Natriuretic Factor | 1998 |
Myocardial degeneration in mice treated with dibutyryl cyclic AMP and/or theophylline.
Topics: Animals; Bucladesine; Cardiomyopathies; Female; Leukemia, Experimental; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Myocardium; Necrosis; Theophylline | 1976 |